Healthtech Series C Investors & VC Firms
771 firms in this list, with a median first check of $1M. 164 of them lead rounds. Generated from verified public data and updated continuously.
Xerys
ParisSeed–Late Stage$16M – $97M
freebit investment
TokyoSeed–Growth
1 person
What If Ventures
FriscoPre-Seed–Late Stage
1 person
Quad Ventures
SeoulPre-Seed–Late Stage
4 people
INP Capital
VancouverSeed–Late Stage
5 people
Maximus Ventures
Seed–Series C
11 people
MPCi (formerly Matrix Partners China)
SingaporeSeed–Growth
11 people
NEOM
RiyadhPre-Seed–Series C
11 people
Pivotal Life Sciences
Seed–Late Stage
5 people
Princeville Capital
San FranciscoSeries A–Late Stage
11 people
Saisei Ventures
CambridgePre-Seed–Growth
5 people
JourneyOne Ventures
BoulderPre-Seed–Growth
1 person
ODYSSEE VENTURE
ParisSeed–Late Stage$1.1M – $11M
1 person
Redhills Ventures LLC
Las VegasSeed–Late Stage$125K – $7M
3 people
Waterpoint Lane
MiamiSeed–Late Stage
2 people
Rapid Scale
Las VegasSeries A–Growth
Redesign Health
New YorkSeed–Late Stage
2 people
Angaza Capital
Abu DhabiSeed–Growth
1 person
HealthCare Ventures, LLC
CambridgeSeries A–Late Stage$1M – $20M
1 person
South China Venture Capital
ShenzhenSeed–Late Stage
4 people
Huangpu River Capital
ShanghaiSeries C–Late Stage
Reverent Partners
SeoulSeries A–Late Stage
Amgen Ventures
Thousand OaksSeed–Late Stage$1M – $3M
1 person
Fluke Venture Partners
KirklandSeed–Late Stage$1M – $4M
1 person
Related lists
Healthtech Investors & VC Firms (3208)Series C Investors & VC Firms (2751)Healthtech Seed Investors & VC Firms (2488)Healthtech Series A Investors & VC Firms (2210)Healthtech Investors & VC Firms in United States (1616)Healthtech Pre-Seed Investors & VC Firms (1328)Healthtech Series B Investors & VC Firms (1216)Healthtech Growth Investors & VC Firms (1213)Series C Investors & VC Firms in United States (946)Series C Investors & VC Firms in Global (896)
Data sourced from public filings and firms' own websites — see our methodology.
















